Xiromed

Pharmaceuticals

United States, New Jersey

$10M to $25M

11-50

Emmaus Life Sciences

Pharmaceuticals

United States, California

$10M to $25M

11-50

Peak Analysis and Automation

Pharmaceuticals

United States, Colorado

$10M to $25M

11-50

Fox Chase Therapeutics Discovery

Pharmaceuticals

United States, Pennsylvania

$10M to $25M

11-50

Evergreen Pharmacy

Pharmaceuticals

United States, Wisconsin

$10M to $25M

11-50

Galt Pharmaceuticals

Pharmaceuticals

United States, Georgia

$10M to $25M

11-50

Wellgistics

Pharmaceuticals

United States, Florida

$10M to $25M

11-50

Murty Pharmaceuticals

Pharmaceuticals

United States, Kentucky

$10M to $25M

11-50

Triple Threat Communications

Pharmaceuticals

United States, New Jersey

$10M to $25M

11-50

Orlando Clinical Research Center

Pharmaceuticals

United States, Florida

$10M to $25M

11-50

Acumen Pharmaceuticals

Pharmaceuticals

United States, Virginia

$10M to $25M

11-50

FDAQRC

Pharmaceuticals

United States, Texas

$10M to $25M

11-50

Midwest Compliance Laboratories

Pharmaceuticals

United States, Indiana

$10M to $25M

11-50

Focus Laboratories

Pharmaceuticals

United States, Arkansas

$10M to $25M

11-50

Magnolia Pharmacy

Pharmaceuticals

United States, Texas

$10M to $25M

11-50

Infuserve America

Pharmaceuticals

United States, Florida

$10M to $25M

11-50

Solaris Pharma Corporation

Pharmaceuticals

United States, New Jersey

$10M to $25M

11-50

Marlex Pharmaceuticals

Pharmaceuticals

United States, Delaware

$10M to $25M

11-50

Hopewell Pharmacy & Compounding Center

Pharmaceuticals

United States, New Jersey

$10M to $25M

11-50

HALDEY Pharmaceutical Compounding

Pharmaceuticals

United States, New York

$10M to $25M

11-50